Selective induction of cell adhesion molecules by proinflammatory mediators in human cardiac microvascular endothelial cells in culture

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 4, 2010, Pages 315-331

  Yan, Jun ^a   Nunn, Adrian D ^a   Thomas, Regi ^a  

^a Bracco Research USA   (United States)

Author keywords

Cell adhesion molecules; E selectin; Endothelium; ICAM 1; Inflammation; LPS; P selectin; PECAM 1; TNF ; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSS REACTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MICROVASCULARIZATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS;

EID: 78649749752     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Barreiro O and Sanchez-Madris F. Molecular basis of leukocyte-endothelium interactions during the inflammatory response. Rev Esp Cardiol 2009; 62:552-556.
2. Montefort S, Holgate ST. Adhesion molecules and their role in inflammation. Respir Med 1991; 59:91-99.
3. Bevilacqua MP and Nelson RM. Endothelialleukocyte adhesion molecules in human disease. Annu Rev Med 1994 45:361-78.
4. Lasky LA Selectins: interpreters of cell-specific carbohydrates information during inflammation. Science 1992; 258: 964-969.
5. Sawa Y, Sugimoto Y, Ueki T, Ishikawa H, Sato A, Ngato T and Yoshida S. Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J Histochemistry and Cytochemistry 55: 721-733.
6. Woodfin A, Reichel CA, Khandoga A, Corada, Voisin M, Scheiermann, Haskard, Dejana E, Krombach F and Nourshargh S. JAM-A mediates neutrophil transmigration in a stimulusspecific manner in vivo: evidence for sequential roles for JAMA-A and PECAM-1 in neutrophil transmigration. Blood 2007;110:1848-1856.
7. Barker J. Adhesion molecules in cutaneous inflammation. Ciba Found Symp 1995; 189:91-106.
8. Bennion SD, Middleton MH, David-Bajar KM, Brice S Norris D. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule (ICAM-1) indicates different triggers of diseases. J Invest Dermatol 1995; 105:71S-79S.
9. De Vries IJM, Langeveld-Wildshut EG, van Reijsen FC, Dubois GR, van den Hoek JA, Bihari IC, van Wichen D, de Weger RA, Knol EF. Adhesion molecule expression on skin endothelia in atopic dermatitis: Effects of TNF-α and IL-4. J Allergy Clin Immunol 1998; 102:461-468.
10. Groves RW, Allen MH, Barker J, MacDonald DM. Endothelial leukocyte adhesion molecule (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124:117-123.
11. Groves RW, Ross EL, Barker J, MacDonald DM. Vascular cell adhesion molecule-1: Expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993; 29:67-71.
12. Garlanda C, Dejana E. Heterogeneity of Endothelial cells: specific markers. Arterioscler Thromb Vasc biol 1997; 17:1193-1202.
13. McDouall RM, Farrar MW, Khan A, Yacoub MH, Allen AP. Unique sensitivities to cytokine regulated expression of adhesion molecules in human heart derived endothelial cells. Endothelium 2001; 8:25-40.
14. Couchman JR. Commercial Antibodies: The Good, Bad, and Really Ugly. J Histochem & Cytochem 2009 57:7-8.
15. Alon R Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr opin Cell boil 2008; 20:525-535.
16. Bonfanti R, Furie B, Wagner D. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells 1989; Blood 73, 1109-1112.
17. Barreiro O, Vicente-Manzanares M, Urzainqui A, YanezMo M, Sancez-Madrid F. Interactive protrusive structures during leukocytes adhesion and transendothelial migration. Fron Biosci 2004; 9:1849-1863.
18. Elices MJ, Osborn L, Takeda Y, Crouse C, Luhowskyj S. VACM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-/fibronectin binding site. Cell 1990; 10:577-584.
19. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocytes function-associated antigen (LFA-1). Cell 1987; 51:813-819.
20. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and Vascular cell adhesion molecule-1 (VCAM-1) in human microvasuclar endothelial cells. J Immunol 1996; 156:2558-2565.
21. May JM, Caroline PD, Wheeler-Jones Pearson JD. Effects of protein kinase inhibitors on cytokine induced adhesion molecule expression by human umbilical vein endothelial cells. Bri J Pharm 1996; 118;1761-1771.
22. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferongamma: tissue distribution, biochemistry and function of natural adherence molecule (ICAM-1) J Immunol 1986; 137:245-254.
23. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol 2003; 15:515-524.
24. Piali L, Hammel P, Uhrek C, Bachmann F. CD31/PECAM-1 is al ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelium. J Pharmacol Sci 1996; 92:7-12.
25. Cepinskas G, Savickiene J, Ionescu CV, Kvietys PR. PMN transendothelial migration decreases nuclear NFkB in IL-1b-activated endothelial cells: role of PECAM-1. J Cell Biol 2003; 161:641-651.
26. Auerbach R., Alby L., Morrissey W., Tu M and Joseph J. Expression of organ specific antigens on capillary endothelial cells. Microvasc. Res. 1985; 29:401-411.
27. Kumar S, West DC, Ager A. Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 1987; 36:57-70.
28. Lodge PA, Haisch GE, Huber SA, Martin B and Craigghead GC. Biological differences in endothelial cells depending upon organ differentiation. Trans Proc 1991; 23, 216-218.
29. Page C, Rose M, Yacoub M, and Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992; 141:673-683.
30. Petzelbauer P, Bender JR., Wilson J and Pober JS. Heterogeneity of dermal microvasular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993; 148:78-83.
31. Swerlick RA, Lee KH, Wick TM and Lawley TI. Human dermal microvascular endothelial cells but not human umbilical vein cells express CD36 in vivo and in vitro J Immunol 1992; 148:78-83.
32. Aird W. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 2007; 100:174-190.
33. Huo Y and Xia L. PSGL-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovascular Med 2009;19:140-145.
34. Etter H, Althaus R, Eugster HP, Santamaria-Babi LF, Weber F L. IL-4 and IL-13 downregulates rolling adhesion of leukocytes to IL-1 or TNF-α activated endothelial cells by limiting the interval of E-selectin expression. Cytokine 1998; 10:395-403.
35. Fukushi J, Ono M, Morikawa W, Iwamoto Y, Kuwano M. The activity of soluble VACM-1 in angiogenesis stimulated by IL-14 and IL-13. J Immunol 2000; 165:2818-2823.
36. Zurawski A, Chomarat, P Djossou O, Bidaud C, Mckenzie AN, Miossec A. The primary biding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Bio Chem 1995; 270:13869-8.
37. Zurawski SM, Vega F, Huyghe B, Zurawski G. Receptors for IL-13 and IL-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12:2663-67.
38. Avesa G, Punnonen J, Cocks B, de Waal Malefyt, R, Vega J, Zurawski S, Zuraski G, and deVries JE. An IL-4 mutant protein inhibits both IL-4 or IL-13 induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Expt Med 1993; 178:2213-17.
39. Zurawski G and deVries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-24.
40. Cardoso L, Araujo MI, Goes AM, Pacifico LG, Oliveira RR, Oliveira SC. Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact 2007; 6:1-6.
41. Wanidworanum C and Strober W. Predominant role of tumor necrosis factor-alpha in human monocytes IL-10 synthesis. J Immunol 1993; 151:6853-6861.
42. Chamoun F, Burne M, O'Donnell M, Rabb H. Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Front BioSci 2000; 5:E103-109.
43. Zhang RL, Chopp M, Li Y, Zaloga C. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 1994; 44:1747-1751.
44. Bowes MP, Zivin JA, Rothlein R. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 1993;119:215-219.
45. Noseworthy, JH, Kirkpatrick P. Natalizumab. Nat Rev Drug Discov 2005; 4:101-102.
46. Marecki S, Kirkpatrik P. Efalizumab. Nat Rev Drug Discov 2004; 3:473-474.